Your browser doesn't support javascript.
loading
Crizotinib Failure in a TPM4-ALK-Rearranged Inflammatory Myofibroblastic Tumor With an Emerging ALK Kinase Domain Mutation.
Tsakiri, Kalliopi; Kotoula, Vassiliki; Lakis, Sotirios; Müller, Judith; Fostira, Florentia; Bobos, Mattheos; Hytiroglou, Prodromos; Fountzilas, George.
Afiliação
  • Tsakiri K; Kalliopi Tsakiri, Vassiliki Kotoula, Mattheos Bobos, and George Fountzilas, Hellenic Foundation for Cancer Research; Vassiliki Kotoula, Prodromos Hytiroglou, and George Fountzilas, Aristotle University of Thessaloniki, Thessaloniki; Kalliopi Tsakiri and George Fountzilas, Thermi Oncology Unit, Therm
  • Kotoula V; Kalliopi Tsakiri, Vassiliki Kotoula, Mattheos Bobos, and George Fountzilas, Hellenic Foundation for Cancer Research; Vassiliki Kotoula, Prodromos Hytiroglou, and George Fountzilas, Aristotle University of Thessaloniki, Thessaloniki; Kalliopi Tsakiri and George Fountzilas, Thermi Oncology Unit, Therm
  • Lakis S; Kalliopi Tsakiri, Vassiliki Kotoula, Mattheos Bobos, and George Fountzilas, Hellenic Foundation for Cancer Research; Vassiliki Kotoula, Prodromos Hytiroglou, and George Fountzilas, Aristotle University of Thessaloniki, Thessaloniki; Kalliopi Tsakiri and George Fountzilas, Thermi Oncology Unit, Therm
  • Müller J; Kalliopi Tsakiri, Vassiliki Kotoula, Mattheos Bobos, and George Fountzilas, Hellenic Foundation for Cancer Research; Vassiliki Kotoula, Prodromos Hytiroglou, and George Fountzilas, Aristotle University of Thessaloniki, Thessaloniki; Kalliopi Tsakiri and George Fountzilas, Thermi Oncology Unit, Therm
  • Fostira F; Kalliopi Tsakiri, Vassiliki Kotoula, Mattheos Bobos, and George Fountzilas, Hellenic Foundation for Cancer Research; Vassiliki Kotoula, Prodromos Hytiroglou, and George Fountzilas, Aristotle University of Thessaloniki, Thessaloniki; Kalliopi Tsakiri and George Fountzilas, Thermi Oncology Unit, Therm
  • Bobos M; Kalliopi Tsakiri, Vassiliki Kotoula, Mattheos Bobos, and George Fountzilas, Hellenic Foundation for Cancer Research; Vassiliki Kotoula, Prodromos Hytiroglou, and George Fountzilas, Aristotle University of Thessaloniki, Thessaloniki; Kalliopi Tsakiri and George Fountzilas, Thermi Oncology Unit, Therm
  • Hytiroglou P; Kalliopi Tsakiri, Vassiliki Kotoula, Mattheos Bobos, and George Fountzilas, Hellenic Foundation for Cancer Research; Vassiliki Kotoula, Prodromos Hytiroglou, and George Fountzilas, Aristotle University of Thessaloniki, Thessaloniki; Kalliopi Tsakiri and George Fountzilas, Thermi Oncology Unit, Therm
  • Fountzilas G; Kalliopi Tsakiri, Vassiliki Kotoula, Mattheos Bobos, and George Fountzilas, Hellenic Foundation for Cancer Research; Vassiliki Kotoula, Prodromos Hytiroglou, and George Fountzilas, Aristotle University of Thessaloniki, Thessaloniki; Kalliopi Tsakiri and George Fountzilas, Thermi Oncology Unit, Therm
JCO Precis Oncol ; 1: 1-7, 2017 Nov.
Article em En | MEDLINE | ID: mdl-35172497
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2017 Tipo de documento: Article